Outperforming ETF manager names a potential -2-
These total returns are all through March 28 and are after expenses and include reinvested dividends:
ETF or mutual fund Ticker Oct. 8, 2021, through March 28, 2024 1 year 3 years 5 years 10 years Simplify Health Care ETF PINK 26.0% 26.7% N/A N/A N/A Fidelity MSCI Health Care Index ETF FHLC 13.8% 17.4% 23% 70% 195% T. Rowe Price Health Sciences Fund, Class I THISX 1.4% 16.0% 13% 64% 210% Fidelity Select Health Care Portfolio FSPHX 0.9% 12.2% 7% 61% 177% Health Care Select Sector SPDR ETF XLV 21.0% 18.2% 32% 78% 201% SPDR S&P 500 ETF Trust SPY 24.1% 34.1% 38% 102% 238%
For the T. Rowe Price Health Sciences Fund, the 10-year performance figure is for the Investor Class shares PRHSX, because the Class I shares were first made available in 2016.
Click on the tickers for more about any company or fund.
Click here for Tomi Kilgore's detailed guide to the wealth of information available for free on the MarketWatch quote page.
Don't miss: Here's how Wall Street analysts' favorite stock picks performed over the past five years
-Philip van Doorn
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
04-06-24 0711ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s Happening in the Markets This Week
-
Worst-Performing Stock ETFs of the Quarter
-
Q3 in Review and Q4 2024 Market Outlook
-
Top-Performing Stock ETFs of the Quarter
-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
5 Stocks to Buy Instead of Overpriced US Equities
-
Consumer Defensives: Despite Angst, Thirsty Investors Have Names to Pursue
-
Industrials: Many Stocks Overvalued After Q3 Outperformance
-
Basic Materials: Despite Index Rise, We See Multiple Long-Term Opportunities
-
What the Election Could Mean for Big Tech Stocks
-
3 Lessons From Recent Stock Market Drama
-
Consumer Cyclicals: Even Amid Moderating Consumer Spending, We See Discounts
-
Healthcare: Valuations Look Fair Overall, With Select Industries Still Undervalued
-
Utilities: Falling Interest Rates, Growth Outlook Boosting Stocks